169303 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Sub-classes:PARTICLE FOR IMMUNOTURBIDIMETRY, REAGENT, TEST KIT, AND METHOD OF DETECTING TARGET SUBSTANCE
#2PARTICLE FOR IMMUNOTURBIDIMETRY, REAGENT, TEST KIT, AND METHOD OF DETECTING TARGET SUBSTANCE
#3METHOD AND DEVICE FOR ANALYSIS OF LIQUID SAMPLES
#4P-SELECTIN MUTANTS AND MODULATION OF INTEGRIN-MEDIATED SIGNALING
#5INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF
#6KIT FOR DETECTING SOLUBLE GROWTH STIMULATION EXPRESSED GENE 2 PROTEIN
#7Application of GLUN2A and NMDA Receptor Containing GLUN2A as Targets in Screening Drugs for Treating Depression
#8ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE
#9Polyamine Reporters
#10CLAUDIN18 ANTIBODIES AND METHODS OF TREATING CANCER
#11MULTIPLE BIOMARKERS FOR DIAGNOSING LUNG CANCER AND USE THEREOF
#12SENSOR, KIT, AND METHOD FOR BIOMARKER DETECTION IN SALIVA
#13SMAGP FUSION MOLECULES AND METHODS OF USE THEREOF
#14METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN
#15BIOLOGICAL STATUS CLASSIFICATION
#16IMPROVED FLUORESCENT PROTEINS
#17TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#18HIGH-THROUGHPUT SCREENING FOR LIGANDS OF TRANSMEMBRANE PROTEINS
#19BIOSENSING OF RECONFIGURABLE ANALYTES USING INTEGRATED NANOPHOTONICS (BRAIN)
#20Method for a preparation of a molecularly-imprinted-polymer (MIP) electrochemical sensor for an electrochemically inactive analyte detection, a method for using said sensor and such a sensor
#21MARKERS OF TOTIPOTENCY AND METHODS OF USE
#22BIOMARKER FOR DIAGNOSING IMMUNE-RELATED DISEASES USING ASPARTATE METABOLITE
#23ANTI-HOG TCN1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
#24MODIFIED IMMUNE CELLS AND USES THEREOF
#25COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR
#26APPLICATION OF PLANT TIM PROTEIN, TIM GENE ENCODING THE SAME OR HOMOLOGOUS GENE OF THE SAME IN PLANT RESISTANCE TO VIRUSES, METHOD FOR OBTAINING VIRUS-RESISTANT PLANT AND METHOD FOR IDENTIFYING ANTIVIRAL CAPABILITY
#27MICROFLUIDIC TRANSWELL SYSTEMS FOR IMAGING PAIRED CELL INTERACTIONS VIA EXOSOMES
#28METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS
#29METHODS AND SYSTEMS FOR CHARACTERIZING PROTEOFORMS OF SIGNIFICANT PROTEINS OF INTEREST
#30TREATMENT OF PAIN
#31COMPUTATIONAL GENERATION OF ARTIFICIAL PROTEINS WITH PROGRAMMABLE IMMUNOGENICITY
#32POINT-OF-CARE BLOOD ANALYSIS SYSTEM
#33TREATMENT OF PAIN
#34METHODS OF DIAGNOSIS AND GUIDING TREATMENT OF VULVOVAGINAL SYMPTOMS AND FEMALE SEXUAL DYSFUNCTION
#35Uses of 5-Aminovaleric Acid Betaine and Compositions Related Thereto
#36NANOPORE SYSTEMS AND METHODS FOR SINGLE-MOLECULE POLYMER PROFILING
#37ANALYTE CHARACTERIZATION BY DIFFERENTIAL BINDING OF BINDING REAGENTS
#38SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY
#39IMMUNORECEPTOR INHIBITORY PROTEINS AND RELATED METHODS
#40AN IMMUNOSENSOR ELECTRODE
#41METHOD FOR DETECTING TRANSTHYRETIN TETRAMER, AND METHOD FOR EVALUATING STABILITY
#42COILED-COIL PEPTIDES FOR FORCE-DEPENDENT APPLICATIONS
#43ARTHROPOD CHEMOSENSORY RECEPTORS AND USES THEREOF
#44PEPTIDE COMPOSITION AND USES THEREOF
#45METHOD FOR SIMULATING SENSITIVE RESPONSE OF JURKAT CELLS IN MECHANICAL MICROENVIRONMENTS
#46Systems, Methods, and Compositions for Generation of Therapeutic Cells
#47ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF
#48PROTEIN MODIFYING REAGENT
#49SELF-ACTIVATING FÖRSTER RESONANCE ENERGY TRANSFER (saFRET) BIOSENSORS AND METHODS FOR MAKING AND USING THEM
#50COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEPSIS
#51DETECTION METHOD FOR IMMUNE PROTEIN OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS (hUC-MSCs)
#52A DEGRON FOR REGULATING PROTEIN EXPRESSION AND METHODS THEREOF
#53COMBINATION THERAPY OF CLAUDIN 18.2 ANTAGONIST AND PD-1/PD-L1 AXIS INHIBITOR
#54CALPROTECTIN BINDING PEPTIDES
#55POLYPEPTIDES AND METHODS OF USE
#56PRECISION MEDICINE FOR TREATMENT OF KIDNEY FUNCTION DECLINE
#57GENETICALLY ENCODED FLUORESCENT INDICATOR OF D-2-HYDROXYGLUTARATE
#58METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE
#59METHODS FOR OBTAINING ANTIBODIES THAT BIND TRANSMEMBRANE PROTEINS AND CELLS THAT PRODUCE THE SAME
#60IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
#61METHOD FOR SCREENING DRUGS FOR TREATING MULTIPLE-VARIANT CORONAVIRUS DISEASE
#62METHOD OF EVALUATING SMALL MOLECULE DISTRIBUTION USING TELLUROPHENE ANALOGUES
#63SURFACE ACTIVATION OF MATERIALS AND MICROARRAY PRINTING FOR USE IN BIOLOGICAL ANALYSIS
#64ANTI-FEL D 1 ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF AND USES THEREOF
#65METHODS OF USING SHAPED PARTICLES IN FLOW CYTOMETERS FOR ASSAYS ON B CELLS AND T CELLS
#66SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES
#67METHODS FOR PREDICTING THE USEFULNESS OF DISEASE SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY
#68MAGEB2 BINDING CONSTRUCTS
#69ENGINEERED CANNABINOID BIOMARKER(S), IN VITRO AND IN VIVO TESTING, AND RELATED APPLICATIONS
#70MOLECULAR INDEXING OF PROTEINS BY SELF ASSEMBLY (MIPSA) FOR EFFICIENT PROTEOMIC INVESTIGATIONS
#71KIT FOR QUANTITATIVE ANALYSIS OF C-REACTIVE PROTEIN, METHOD FOR QUANTITATIVE ANALYSIS OF C-REACTIVE PROTEIN, AND APPARATUS FOR PERFORMING THE SAME
#72METHODS FOR IDENTIFYING BINDING PARTNERS OF PROGRANULIN
#73AIT1 PROTEIN AND METHODS OF CONTROLLING EUKARYOTIC METABOLISM
#74SIMULTANEOUS IMAGING OF NUCLEIC ACID AND PROTEIN IN A SAMPLE
#75Random Heteropolymers Preserve Protein Function in Foreign Environments
#76METHOD FOR DIFFERENTIATION OF OCULAR CELLS AND USE THEREOF
#77NOVEL INSECT INHIBITORY PROTEINS
#78METHOD FOR DIFFERENTIATION OF OCULAR CELLS AND USE THEREOF
#79Anti-Polyubiquitin Antibodies
#80METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY
#81NOVEL INSECTICIDAL TOXIN RECEPTORS AND METHODS OF USE
#82PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
#83NOVEL TWO ELECTRODE-BASED CORRECTION APPROACH FOR ELIMINATION OF BIOFOULING FROM LABEL-FREE AFFINITY BIOSENSORS FOR DETECTION
#84METHOD AND KIT FOR REDUCING INTERFERENCES IN IMMUNOASSAYS
#85ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
#86RAPID DETECTION METHOD FOR ABRIN TOXIN
#87COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODAMAGE
#88CLICK-CHEMISTRY FUNCTIONALIZED COMPOUNDS AND METHODS OF CONJUGATION
#89SYSTEM AND METHOD FOR OPTOGENETICS STIMULATION OF NEURAL TISSUES ON MICROELECTRODE ARRAYS
#90APOLIPOPROTEIN E ISOYPE DETECTION BY MASS SPECTROMETRY
#91EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS
#92PARTICLE, TEST PARTICLE, REAGENT, AND TEST KIT, AND DETECTION METHOD
#93PARTICLE, TEST PARTICLE, REAGENT, AND TEST KIT, AND DETECTION METHOD
#94Methods for Sample Quality Assessment
#95BEDBUG DETECTION, MONITORING AND CONTROL TECHNIQUES
#96BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY
#97TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS
#98METHOD FOR VISUALIZING DENATURED STATE OR AGGREGATED STATE OF PROTEIN
#99LFA3 VARIANTS AND COMPOSITIONS AND USES THEREOF
#100THERAPEUTIC REGIMENS FOR CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELLS
#101THERAPEUTIC mRNA
#102METHOD FOR EXAMINING BLOOD SAMPLE
#103SYSTEMS AND METHODS OF OPTICALLY DETERMINING ANALYTE CONCENTRATIONS
#104FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN PROGRANULIN
#105INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE
#106Multiplexed Analyses of Test Samples
#107SMALL MOLECULE INHIBITOR TARGETING A LEUKEMIC STEM CELL ASSOCIATED GENE FOR HIGH-RISK AML PATIENTS
#108Liposome-containing Diagnostic Reagents and Methods of Production and Use Thereof
#109Bed Bugs Detection Device
#110Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigens
#111METHODS FOR IDENTIFYING AND USING ALLOGENEIC TUMOR INFILTRATING LYMPHOCYTES TO TREAT CANCER
#112Anti-Polyubiquitin Multispecific Antibodies
#113BIOMARKER AND PATIENT SELECTION IN TREATMENT FOR MYELOFIBROSIS
#114RECOMBINANT TYPE I ALLERGEN OF ARTEMISIA ANNUA POLLEN, AND PREPARATION METHOD AND USE THEREOF
#115REAGENT KIT, MEASUREMENT KIT, AND MEASUREMENT METHOD
#116METHODS FOR BALANCING ENCODING SIGNALS OF ANALYTES
#117HIGH AFFINITY HUMAN AND MONKEY SPECIFIC TFR-1 VNARS
#118ANTI-NKG2A ANTIBODIES AND USES THEREOF
#119BINDING PROTEINS SPECIFIC FOR CD32A
#120COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE
#121THYROGLOBULIN QUANTITATION BY MASS SPECTROMETRY
#122VEGF MUTANTS AND MODULATION OF INTEGRIN-MEDIATED SIGNALING
#123TRANSCRIPTION FACTOR NCGL0581 MUTANT AND USE THEREOF IN L-SERINE DETECTION
#124METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS
#125MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING
#126IDENTIFYING NEW THERAPEUTIC AGENTS
#127MULTI-COMPONENTED STRUCTURE FOR CAPTURING COMPOUND
#128METHOD OF TREATING AN AUTOIMMUNE DISEASE BY ADMINISTERING AN ANTI-HUMAN BAFF ANTIBODY
#129METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS
#130NEUROKININ ANTAGONISTS AND USES THEREOF
#131DIAGNOSTIC ASSAY USING MAGNETIC PARTICLES
#132METHODS AND KITS USING NUCLEIC ACID ENCODING AND/OR LABEL
#133ANTI-B7-H3 MONOCLONAL ANTIBODY AND USE THEREOF IN CELL THERAPY
#134CDH17 ANTIBODIES AND METHODS OF TREATING CANCER
#135MATERIALS AND METHODS FOR ENHANCED DETECTION AND SCREENING OF MOLECULES OF THERAPEUTIC POTENTIAL
#136FAP DETECTION
#137ANTI-PD1 MONOCLONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
#138IMMUNOASSAY USING MAGNETIC MICROSPHERES
#139Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#140EXTRACTION METHOD AND USE OF CUCUMBER RIBOSOME
#141MARKERS SPECIFIC FOR PLURIPOTENT STEM CELLS, AND METHODS OF USING THE SAME
#142LATERAL FLOW IMMUNOASSAY DEVICE FOR ALBUMIN DETECTION
#143SCREENING METHOD FOR DROUGHT-RESISTANT GERMPLASM OF OPHIOPOGON JAPONICUS
#144ANTIBODY AGAINST HUMAN TIGIT AND USE THEREOF
#145IMMUNOGENIC ANTIGEN IDENTIFICATION FROM A PATHOGEN AND CORRELATION TO CLINICAL EFFICACY
#146ANTIBODIES TARGETING PHOSPHORYLATED SEVEN-TRANSMEMBRANE RECEPTORS
#147Systems and Methods for Performing a Real-Time Glycan Assay of a Sample
#148A METHOD OF DETERMINING THE PRESENCE OF AN ANALYTE IN A SAMPLE
#149AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#150SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES
#151COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC TEST STRIP FOR DETECTING ENRAMYCIN, PREPARATION METHOD, AND APPLICATION THEREOF
#152METHODS OF DETECTING CANCER
#153ARTIFICIAL BIOMEMBRANE CONTAINING MEMBRANE PROTEIN
#154COMPOSITIONS, SYSTEMS, AND METHODS FOR DETERMINATION OF T2R AND/OR T1R PHENOTYPE IN INDIVIDUALS TO PREDICT CANNABIS TASTING PREFERENCES, CHARACTERIZATION OF CANNABIS IN RELATION TO INDIVIDUAL TASTING PREFERENCES, AND SELECTION OF CANNABIS
#155Camera-based hemoglobin detection
#156IMMUNOCHROMATOGRAPHIC KIT
#157HUMANIZED ANTI-EGFR VIII ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF
#158METHODS AND MATERIALS FOR LARGE-SCALE ASSESSMENT OF LIGAND BINDING SELECTIVITY OF G-QUADRUPLEX RECOGNITION USING CUSTOM G4 MICROARRAYS
#159SINGLE-CELL MULTI-OMICS TOOL WITH PHENOTYPIC ASSESSMENT
#160VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE
#161ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF
#162SELECTION INHIBITION OF DNA POLYMERASE BETA BY A COVALENT INHIBITOR
#163ELECTROCHEMICAL SHOTGUN TAGGING ASSAY
#164METHOD FOR QUANTITATIVELY ANALYZING FLUORESCENT DYES LABELED ON EXTRACELLULAR VESICLE BY USING FLUORESCENCE CORRELATION SPECTROSCOPY, AND USE THEREOF
#165SUBSTRATES AND BIOMARKERS OF ADAMTS7
#166LIVE YEAST BIOSENSORS AND METHODS OF USE THEREOF
#167ANTI-TROP2 SINGLE-DOMAIN ANTIBODY AND USE THEREOF
#168SPYCATCHER ANALOGS AND USES THEREOF
#169STRUCTURES OF LANGYA VIRUS FUSION PROTEIN ECTODOMAIN AND IMMUNOGENIC COMPOSITIONS DERIVED THEREFROM
#170ENGINEERED FLUORESCENT SPONTANEOUS ISOMERIZATION RATE BIOSENSORS
#171COMBINATORIAL USE OF MARKERS TO ISOLATE SYNAPTIC GLIA TO GENERATE SYNAPSES IN A DISH FOR HIGH-THROUGHPUT AND HIGH-CONTENT DRUG DISCOVERY AND TESTING
#172SPECIFIC BACULOVIRUS MAJOR ENVELOPE GLYCOPROTEIN GP64 BINDING PROTEINS
#173METHODS AND KITS FOR DETECTING CANNABINOIDS
#174C3B INACTIVATING POLYPEPTIDE
#175Biomarkers of Marine Invertebrate Stress
#176COMPOSITIONS AND METHODS OF A CONCOMITANT THERAPY OF ALTERNATING ELECTRIC FIELDS AND N-CADHERIN INHIBITOR
#177TREATMENT OF BRAIN METASTASES AND CNS METASTASES USING ILLUDINS OR HYDROXYLUREAMETHYL ACYLFULVENE
#178METHOD FOR EVALUATING AGGREGATION STATE OF AGGREGATIVE PROTEIN
#179METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY
#180NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY
#181Affinity ligands for the purification and detection of ubiquitin muteins
#182METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DYING FROM BREAST CANCER OR PROSTATE CANCER
#183Bed bugs detection device
#184CD8A-Binding Fibronectin Type III Domains
#185PHOTORESPONSIVE PROTEIN AND UTILIZATION THEREOF
#186COMPOSITIONS AND METHODS FOR TREATING AND/OR IDENTIFYING AN AGENT FOR TREATING INTESTINAL CANCERS
#187OLFACTORY RECEPTOR EXPRESSING METHOD AND RESPONSE MEASUREMENT METHOD
#188Systems and Methods for Assessment of Lipid Membrane-Associated Molecule Kinetics, Dynamics, and Interactions
#189METHOD OF IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#190FULLY HUMAN ANTIBODY FOR HUMAN B7H3, CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
#191METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN
#192BIOMARKER FOR PREDICTING RESPONSE TO IMMUNE CHECKPOINT INHIBITOR
#193COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#194PROTEIN MELT ANALYSIS USING DIPYRROMETHENEBORON DIFLUORIDE COMPOUNDS
#195SINGLE DOMAIN ANTIBODY AGAINST PD-L1 AND USE THEREOF
#196SINGLE DOMAIN ANTIBODY AGAINST CD47 AND USE THEREOF
#197Apolipoprotein e isotype detection by mass spectrometry
#198METHOD FOR DETERMINING FIBRINOGEN
#199METHOD FOR MEASURING RESPONSE OF OLFACTORY RECEPTOR TO SUBSTANCE
#200Method For Fractionation Of Biomolecules
#201FOOD ALLERGEN DETECTION DEVICE AND METHODS OF USE THEREOF
#202SMALL-MOLECULE-ACTIVATED GLYCAN MODIFYING ENZYMES AND USES THEREOF
#203ANTI-CNTN4-SPECIFIC ANTIBODIES AND USE THEREOF
#204Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
#205PEPTIDE AND PEPTIDE-CONTAINING COMPOSITION
#206Ultrasensitive Label-Free Profiling of Glycans Released from Single Cells
#207IMPROVED DETECTION OF HEMOGLOBIN AND OTHER COMPOUNDS BY ELECTROPHORESIS
#208INDICATOR RAPIDLY RESPONDING TO SUBTLE PH CHANGE
#209Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin
#210Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin
#211METABOLIC BIOMARKER SET FOR ASSESSING OVARIAN CANCER
#212BRAIN NATRIURETIC PEPTIDE APTAMER FLUORESCENCE DETECTION DEVICE BASED ON SMART PHONE AND SENSING METHOD OF SAME
#213PLANT CELL MATRICES AND METHODS THEREOF
#214Neuromodulation techniques
#215Protein Tyrosine Phosphatases as Biomarkers for Hepatocellular Carcinoma and Uses Thereof
#216COMPOSITIONS AND METHODS FOR TREATMENT OF MITOCHONDRIAL RESPIRATORY CHAIN DYSFUNCTION AND OTHER MITOCHONDRIAL DISORDERS
#217ANTI-HUMAN CD73 ANTIBODY AND USE THEREOF
#218CD131 BINDING PROTEINS AND USES THEREOF
#219PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS
#220MULTI-COMPONENT SYSTEMS FOR DETECTING COVID FROM BLOOD
#221MULTI-COMPONENT SYSTEMS FOR DETECTING COVID FROM SPUTUM AND SALIVA
#222METHODS OF IDENTIFYING AND TREATING A PERSON HAVING A PREDISPOSITION TO OR AFFLICTED WITH A CARDIOMETABOLIC DISEASE
#223SYNTHETIC PHAGE WITH RECOMBINANT TAIL-SPIKE PROTEINS AND RELATED METHODS
#224[18F]A1F LABELED PSMA TARGETING MOLECULAR PROBE AND PREPARATION METHOD THEREFOR
#225COLLECTION AND USES OF TISSUE RESIDENT INTERSTITIAL EXTRACELLULAR VESICLES
#226METHODS TO PREVENT TERATOGENICITY OF IMID LIKE MOLECULES AND IMID BASED DEGRADERS/PROTACS
#227IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
#228THERAPEUTIC OLIGONUCLEOTIDES
#229BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION
#230SINGLE DOMAIN ANTIBODY AGAINST PD-L1 AND USE THEREOF
#231SINGLE DOMAIN ANTIBODY AGAINST CD47 AND USE THEREOF
#232TARGET FOR SCREENING ANTI-TUMOR DRUG, USE THEREOF AND SCREENING METHOD THEREFOR
#233BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF
#234TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS
#235Methods and Compositions for Highly Sensitive Detection of Molecules
#236CD40 BINDING MOLECULES AND USES THEREOF
#237Compositions and methods for treating cancer
#238PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#239Serum Albumin-Binding Fibronectin Type III Domains
#240METHODS AND MATERIALS FOR USING BIOMARKERS WHICH PREDICT SUSCEPTIBILITY TO CLOSTRIDIUM DIFFICILE INFECTION
#241INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS
#242Highly Sensitive System and Method for Analysis of Troponin
#243Genetically encoded biosensors
#244BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF
#245ANTI-IL4 RECEPTOR ANTIBODIES FOR VETERINARY USE
#246Methods and Compositions for Targeting Polyubiquitin
#247METHODS FOR DETECTING SQUAMOUS CANCER
#248IN VIVO METHODS FOR SELECTING PEPTIDES THAT CROSS THE BLOOD BRAIN BARRIER, RELATED COMPOSITIONS AND METHODS OF USE
#249IDENTIFYING NEW THERAPEUTIC AGENTS
#250COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE
#251NON-INVASIVE METHODS OF DETECTING TARGET MOLECULES
#252METABOLIC AUGMENTATION TO PROMOTE AND ENHANCE IMMUNE RESPONSE BY TCF1+ T CELL REPOPULATION
#253Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof and method of use thereof
#254GALECTIN-10 ANTIBODIES
#255Anti-GPC3 antibody
#256METHODS AND SYSTEMS FOR PERFORMING SINGLE CELL ANALYSIS OF MOLECULES AND MOLECULAR COMPLEXES
#257ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
#258METHOD AND SYSTEM FOR THE NON-DESTRUCTIVE IN OVO DETERMINATION OF FOWL GENDER
#259RECONSTITUTION OF A SPLIT-HALOTAG VIA ORTHOGONAL TAG-BINDING DOMAINS
#260Compositions and Methods for Diagnosis and Treatment of Cancer
#261METHODS OF TREATING DISEASES AND DISORDERS
#262METHOD FOR EVALUATING CYSTINE UPTAKE ABILITY OF CELL, KIT FOR EVALUATING CYSTINE UPTAKE ABILITY OF CELL, METHOD FOR DETERMINING SELENOCYSTEINE, AND KIT FOR DETERMINING SELENOCYSTEINE
#263DIAGNOSTICS SYSTEMS AND METHODS
#264BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF
#265SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES
#266FERRITIN MEASURING REAGENT
#267Methods for Using Collagen Hybridizing Peptides to Determine Collagen Content
#268PROTEIN DETECTION AND TRACKING USING NUCLEOSIDE TAGS
#269INDIRECT ENZYME-LINKED IMMUNOSORBENT ASSAY DETECTION KIT BASED ON P30 PROTEIN AND P22 PROTEIN OF AFRICAN SWINE FEVER VIRUS
#270MIC-1 COMPOUNDS AND USES THEREOF
#271Methods of determining the function of polyubiquitin using anti-polyubiquitin antibodies
#272Methods and kits using nucleic acid encoding and/or label
#273PEPTIDES AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#274COMPOSITIONS AND METHODS FOR THE DETECTION AND MOLECULAR PROFILING OF MEMBRANE BOUND VESICLES WITH NANOPARTICLES
#275METHOD OF MAKING PROTEIN
#276TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#277DIAGNOSTIC METHODS AND COMPOSITIONS
#278Insect inhibitory proteins
#279DEVICES AND METHODS FOR DETECTING A TARGET ANALYTE OF INTEREST
#280USE OF GENE INVOLVED IN PASSAGE THROUGH BRAIN-BLOOD BARRIER AND SURVIVAL INSIDE BRAIN OF CAUSATIVE FUNGI OF MENINGOENCEPHALITIS
#281METHODS OF DIAGNOSING BRAIN INJURY
#282VIOLET EXCITABLE TANDEM DYES, AND METHODS FOR MAKING AND USING THE SAME
#283MATURATION SUPPRESSOR AND MATURATION SUPPRESSION METHOD FOR DENDRITIC CELLS, AND PHARMACEUTICAL COMPOSITION
#284STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF
#285Conjugation Reagents and Methods Using 1,2-Cyclohexanediones
#286RECOMBINANT VECTOR FOR PRODUCING ANTIGEN FOR DIAGNOSIS OF AFRICAN SWINE FEVER AND USE THEROF
#287COMBINED THERAPY AGAINST CANCER
#288NOVEL ACRYLATE DERIVATIVES AND USES THEREOF
#289Nanoparticles and distinct exosome subsets for detection and treatment of cancer
#290DIAGNOSIS METHOD FOR BLADDER CANCER
#291METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS
#292EVALUATION METHOD FOR PROTEIN-CONTAINING SOLUTION
#293METHOD FOR QUANTIFYING ADIPONECTIN AND ANALYTICAL REAGENT USED THEREOF
#294Thyroglobulin quantitation by mass spectrometry
#295USE OF HEPARIN-BINDING PROTEIN (HBP) IN EARLY WARNING OF PROGNOSTIC RISK OF PATIENT SUFFERING CORONAVIRUS DISEASE (COVID-19)
#296ASSESSING AND TREATING BIOLOGICAL AGING
#297Means and methods for single molecule peptide sequencing
#298System and methods for multiplexed analysis of cellular and other immunotherapeutics
#299METHOD FOR IDENTIFYING COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER
#300Random heteropolymers preserve protein function in foreign environments